While many studies have focused on the function of HAVCR2 in T cells, we observed an increase in HAVCR2 in NK cells from all CRC patients, and the LGALS9-HAVCR2 axis was found to be specifically involved in NK cell function in CRC. This evidence concerns the gene LGALS9 and colorectal carcinoma.